Nutritional and therapeutic approaches to modulate NADPH oxidase-derived ROS signaling in platelets.

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|21|41|5945-5950

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.21, Iss.41, 2015-12, pp. : 5945-5950

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Editorial (Thematic Issue: NADPH Oxidase-Derived ROS Signaling and Therapeutic Opportunities)

By  

Current Pharmaceutical Design, Vol. 21, Iss. 41, 2015-12 ,pp. : 5931-5932

Bentham Science Publishers

Access to resources Recommend Favorite

NADPH Oxidase and Neurodegeneration

By  

Current Neuropharmacology, Vol. 10, Iss. 4, 2012-12 ,pp. : 321-327

Bentham Science Publishers

Access to resources Recommend Favorite

New Therapeutic Approaches by Using Microorganism-Derived Compounds

By  

Current Medicinal Chemistry, Vol. 19, Iss. 22, 2012-01 ,pp. : 3822-3840

Bentham Science Publishers

Access to resources Recommend Favorite

NADPH oxidase inhibitors: a patent review

By Kim Jung-Ae   Neupane Ganesh Prasad   Lee Eung Seok   Jeong Byeong-Seon   Park Byung Chul   Thapa Pritam  

Expert Opinion on Therapeutic Patents, Vol. 21, Iss. 8, 2011-08 ,pp. : 1147-1158

Informa Healthcare

Access to resources Recommend Favorite

Inhibitory effect of reinioside C on vascular smooth muscle cells proliferation induced by angiotensin II via inhibiting NADPH oxidase-ROS-ERK1/2-NF-κB-AP-1 pathway

By  

Die Pharmazie - An International Journal of Pharmaceutical Sciences, Vol. 69, Iss. 9, 2014-09 ,pp. : 698-703

Govi-Verlag

Access to resources Recommend Favorite